Central analgesic mechanism

Central analgesic mechanism refers to the complex physiological processes within the central nervous system (CNS) that modulate and suppress the perception of pain (StatPearls, 2023). This system primarily involves the activation of descending inhibitory pathways originating in brainstem regions such as the periaqueductal gray (PAG) and the rostral ventromedial medulla (RVM), which project to the spinal cord dorsal horn to attenuate nociceptive signaling (Nature Reviews Neuroscience, 2016). These pathways utilize various neurotransmitters, including endogenous opioids, serotonin, and norepinephrine, to regulate the transmission of pain signals (Journal of Clinical Investigation, 2010). Pharmacological interventions targeting these mechanisms often involve agonists of opioid receptors or inhibitors of neurotransmitter reuptake to enhance natural inhibitory control. While central analgesics are highly effective for managing severe acute and chronic pain, they are frequently associated with significant systemic side effects, including sedation, respiratory depression, and a high risk of physical dependence or addiction (NIH, 2022). Because this term describes a functional outcome or a collection of pathways rather than a single molecular entity, it is classified as a physiological process rather than a specific therapeutic target.

Other names

Central pain modulationDescending inhibitory pain controlCentral antinociceptive systemEndogenous pain control system

Modulation of nociceptive transmission through the activation of descending inhibitory pathways and the inhibition of ascending excitatory pathways in the spinal cord and brain.